ARCHIVES

NRC considering “Escalated” Enforcement Action Against NIH

This article is from The Cancer Letter archive.

Vol. 22 No. 05 | February 2, 1996

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

Community Oncology Alliance Attack On Republican Leadership Prompts Others To Declare: We Aren’t COA.

September 29, 2006

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001